Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$21.94 - $42.51 $117,422 - $227,513
-5,352 Closed
0 $0
Q4 2021

Feb 09, 2022

SELL
$36.09 - $53.79 $3,248 - $4,841
-90 Reduced 1.65%
5,352 $221,000
Q3 2021

Nov 12, 2021

BUY
$35.62 - $52.97 $1,246 - $1,853
35 Added 0.65%
5,442 $253,000
Q2 2021

Aug 16, 2021

BUY
$32.94 - $56.62 $10,837 - $18,627
329 Added 6.48%
5,407 $216,000
Q1 2021

May 14, 2021

SELL
$44.47 - $81.38 $12,051 - $22,053
-271 Reduced 5.07%
5,078 $273,000
Q4 2020

Feb 16, 2021

SELL
$32.49 - $61.88 $67,741 - $129,019
-2,085 Reduced 28.05%
5,349 $262,000
Q3 2020

Nov 12, 2020

BUY
$26.73 - $35.67 $198,710 - $265,170
7,434 New
7,434 $242,000

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.57B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track First Republic Investment Management, Inc. Portfolio

Follow First Republic Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.